0.46 USD
▲-0.00+3.34%
盘后 0.45 +0.87%
2026-08-03
市值
$16.18M
市盈率
—
EPS
-0.39
股息率
—
52 周区间
0.30 – 1.24
成交量
258.46K
Beta
0.72
目标价
—
52W 低 0.3052W 高 1.24
价格走势
公司简介
OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-...